Solid organ transplantation during the COVID-19 pandemic in the United States.

The emergence of SARS-CoV-2 and the clinical syndrome of COVID-19 have significantly disrupted routine health care and life-saving procedures, including solid organ transplantation. The initial lack of personal protective equipment (PPE), the high infectivity, and rapid spread resulted in a change of practice in many transplant centers, including pausing living donor transplantation and limiting solid organ transplant to those waitlist candidates in urgent need of transplant.